# NHS National Framework for Transition products commencing 1 February 2025

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £11,328,000
- Published: 14 October 2024
- Planned start: 1 February 2025
- Planned end: 31 May 2026
- Stage: open_tender
- Procurement category: goods
- Notice ID: a689848e-d5a5-4844-ad5a-3e5fcf4a27d6-793712
- OCID: ocds-b5fd17-e25b1d17-f63d-4316-af2f-fbc0013b4240

## Description

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend \(at the discretion of the Authority\) up to maximum of 24 months\. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 \(16 months\) Lot 2 LSNE: 01/02/2025 to 31/05/2026 \(16 months\) Lot 3 NWLN: 01/02/2025 to 31/05/2026 \(16 months\) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value &amp; Access, NHS England Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family\.force\.com/s/Welcome\. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis\.co\.uk

## Related contract awards

- [NHP Information Management Project Controls Platform](/contracts/ocds-b5fd17-4fcc30c7-0eb2-417b-a7da-de99843314bd): NHS England
- [SolarWinds Licensing and Support - 2026-29](/contracts/ocds-b5fd17-6db83b63-5b91-42b9-bb0d-13c34a9c513c): NHS England
- [Digital Delivery Partner 2](/contracts/ocds-b5fd17-23c40d21-efdc-4afc-9cb6-4de6f39a65f1): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/a689848e-d5a5-4844-ad5a-3e5fcf4a27d6-793712)
